Vanguard Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,439,571	Closed	-$218M	–	4644
2022 Q3	$218M	Buy	1,439,571 +7,113	+0.5%	+$1.05M	0.01%	1333
2022 Q2	$209M	Buy	1,432,458 +10,732	+0.8%	+$1.37M	0.01%	1399
2022 Q1	$169M	Buy	1,421,726 +52,635	+4%	+$6.56M	﹤0.01%	1649
2021 Q4	$189M	Sell	1,369,091 -8,890	-0.6%	-$1.13M	﹤0.01%	1648
2021 Q3	$191M	Buy	1,377,981 +56,711	+4%	+$7.08M	﹤0.01%	1638
2021 Q2	$128M	Buy	1,321,270 +48,374	+4%	+$3.93M	﹤0.01%	1862
2021 Q1	$87M	Buy	1,272,896 +124,655	+11%	+$10.1M	﹤0.01%	2025
2020 Q4	$98.4M	Buy	1,148,241 +97,739	+9%	+$8.28M	﹤0.01%	1842
2020 Q3	$68.3M	Sell	1,050,502 -454,285	-30%	-$29.8M	﹤0.01%	1861
2020 Q2	$110M	Buy	1,504,787 +110,271	+8%	+$5.87M	﹤0.01%	1624
2020 Q1	$47.5M	Buy	1,394,516 +383,632	+38%	+$17.5M	﹤0.01%	1888
2019 Q4	$55M	Buy	1,010,884 +118,639	+13%	+$5.87M	﹤0.01%	2062
2019 Q3	$37.2M	Sell	892,245 -262,012	-23%	-$11.1M	﹤0.01%	2207
2019 Q2	$50.5M	Buy	1,154,257 +294,098	+34%	+$16.6M	﹤0.01%	2097
2019 Q1	$44.3M	Buy	860,159 +191,923	+29%	+$8.29M	﹤0.01%	2151
2018 Q4	$24.7M	Buy	668,236 +131,725	+25%	+$4.75M	﹤0.01%	2357
2018 Q3	$20.1M	Buy	536,511 +20,785	+4%	+$765K	﹤0.01%	2575
2018 Q2	$20.4M	Buy	515,726 +228,776	+80%	+$7.26M	﹤0.01%	2556
2018 Q1	$7.39M	Buy	286,950 +100,487	+54%	+$3M	﹤0.01%	2972
2017 Q4	$5.03M	Buy	186,463 +50,615	+37%	+$1.39M	﹤0.01%	3136
2017 Q3	$5.08M	Buy	135,848 +7,746	+6%	+$235K	﹤0.01%	3113
2017 Q2	$3.2M	Buy	+128,102	New	+$2.95M	﹤0.01%	3243

Other funds holding BHVN